VALIANT LABORATORIES
|
The Current P/E Ratio of VALIANT LABORATORIES is -229.60.
Share Price | ₹93.2 | Jul 22,2025 |
Market Cap | ₹505.8 Cr | |
Earnings-TTM | ₹-2.2 Cr | TTM-Consolidated Results |
Price/Earnings | -229.60x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹505.8 Cr] as on Jul 22,2025
(/) Earnings [ ₹-2.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -229.60x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay -229.60 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES
PE Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2023 averaged 989.13x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 1978.26x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 1978.26x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VALIANT LABORATORIES | -2.20 | -229.60 | 505.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.67 | 402,620.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.10 | 175,509.0 |
CIPLA LTD | 5,291.05 | 22.37 | 118,336.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 62.05 | 118,571.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.15 | 103,522.0 |
MANKIND PHARMA LTD | 2,003.22 | 55.02 | 110,225.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.85 | 96,231.2 |
LUPIN LTD | 3,306.26 | 26.29 | 86,912.2 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.19 | 63,957.9 |
ABBOTT INDIA LTD | 1,414.44 | 51.37 | 72,656.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -229.60x |
Max industry PE | 80.10x |
Median industry PE | 26.29x |
Average industry PE | 14.68x |
You may also like the below Video Courses